Academic literature on the topic 'Discoid lupus erythematosus (DLE)'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Discoid lupus erythematosus (DLE).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Discoid lupus erythematosus (DLE)"

1

Khallaayoune, Mehdi, Siham Belmourida, Fatima Azzahra Elgaitibi, and Mariame Meziane. "Eyelid discoid lupus erythematosus." Our Dermatology Online 12, e (2021): e28-e28. http://dx.doi.org/10.7241/ourd.2021e.28.

Full text
Abstract:
Discoid lupus erythematosus (DLE) most commonly affects the face and scalp. Palpebral involvement is rare and not evocative when presenting as the prime manifestation of the disease. We report hereby the case of a young male patient with isolated palpebral and labial DLE. A 34-year-old patient with no medical history was referred from ophthalmology for an erythematous plaque of the eyelid resisting usual treatment of blepharitis. Skin examination revealed a congestive erythema on the right lower eyelid with eyelash fall (Fig. 1). There was also an atrophic cheilitis of the lower lip with sligh
APA, Harvard, Vancouver, ISO, and other styles
2

Le, Marilyn, Payvand Kamrani, and L. Claire Hollins. "Coexistentence of Morphea and DLE in a Patient with Beta Thalassemia Leading to a Diagnosis of Systemic Lupus Erythematous." SKIN The Journal of Cutaneous Medicine 6, no. 3 (2022): 243–45. http://dx.doi.org/10.25251/skin.6.3.11.

Full text
Abstract:
Patients with autoimmune disorders are predisposed to developing a second autoimmune condition. This can be applied to cutaneous conditions as well. Morphea or localized scleroderma is an autoimmune inflammatory and fibrosing skin disorder due to increased collagen deposition.1,2 Patients with morphea are four times likelier of having a concomitant autoimmune disease.1 There have been cases of systemic lupus erythematosus (SLE) with morphea, but the co-occurrence of discoid lupus erythematosus (DLE) with morphea has been rarely reported, and never reported in patient with Beta-thalamessmia.1,2
APA, Harvard, Vancouver, ISO, and other styles
3

Karasińska, Aneta, Adriana Polańska, Monika Bowszyc‑Dmochowska, Ryszard Żaba, Zygmunt Adamski, and Aleksandra Dańczak‑Pazdrowska. "Discoid lupus erythematosus – a case report, diagnostic and therapeutic difficulties." Journal of Face Aesthetics 4, no. 2 (2021): 135–44. http://dx.doi.org/10.20883/jofa.51.

Full text
Abstract:
Discoid lupus erythematosus is the most common clinical manifestation of lupus erythematosus. Characteristic features are erythematous plaques with follicular hiperkeratosis, clearly demarcated from surrounding skin, that resolve with atrophy and scarring, leading to significant aesthetic defects. The consequence of involving the scalp is cicatrical alopecia. On the ground of long lasting, untreated lesions squamous cell carcinoma (SCC) may develop. On the other hand SCC remains in the circle of DLE differentiation. We present diagnostic and therapeutic difficulties associated with DLE.
APA, Harvard, Vancouver, ISO, and other styles
4

Donaldo, Emiliano Silva López, Antonio Velarde Chávez José, Elisa González Robles María, Fernanda Romero Rivera María, Villaseñor Angulo Saúl, and Alejandra Solano Mendoza Alma. "Considerations in Discoid Lupus: A Comprehensive Review." INTERNATIONAL JOURNAL OF MEDICAL SCIENCE AND CLINICAL RESEARCH STUDIES 04, no. 05 (2024): 818–21. https://doi.org/10.5281/zenodo.11146570.

Full text
Abstract:
Discoid lupus erythematosus (DLE) is a chronic inflammatory skin condition that can lead to disfiguring scarring and pigmentary changes. This review article provides an overview of the epidemiology, pathogenesis, clinical manifestations, and treatment options for DLE. Special considerations in the management of DLE, including the role of photoprotection, topical and systemic therapies, and the importance of multidisciplinary care, are discussed. The impact of DLE on quality of life and psychosocial well-being is also addressed. A better understanding of the complexities of DLE can aid clinicia
APA, Harvard, Vancouver, ISO, and other styles
5

Nakamura, Satoshi, Tomoko Yamada, Naoka Umemoto, et al. "Cheek and Periorbital Peculiar Discoid Lupus Erythematosus: Rare Clinical Presentation Mimicking Tinea Faciei, Cutaneous Granulomatous Disease or Blepharitis." Case Reports in Dermatology 7, no. 1 (2015): 56–60. http://dx.doi.org/10.1159/000381208.

Full text
Abstract:
We present clinically peculiar facial discoid lupus erythematosus (DLE) that mimicked tinea faciei. Although DLE is a chronic autoimmune dermatosis, it has a variety of rare clinical presentations, including periorbital DLE, comedonic DLE and hypertrophic DLE recently. In this case, a scaly, erythematous lesion on the eyelid and the central healed, mildly elevated, annularly distributed facial DLE mimicked tinea faciei, complicating our diagnosis.
APA, Harvard, Vancouver, ISO, and other styles
6

Devaraj, Yogesh, Belagola Dasegowda Sathyanarayana, Mukunda Ranga Swaroop, Sowmya Shree H., Mithila Ravindranath, and Avik Ghosh. "Discoid lupus erythematosus in acro-orificial vitiligo." International Journal of Research in Dermatology 4, no. 3 (2018): 456. http://dx.doi.org/10.18203/issn.2455-4529.intjresdermatol20183178.

Full text
Abstract:
<p class="abstract">Discoid lupus erythematosus (DLE) is an autoimmune disease characterized by atrophic and discoid plaques over sun-exposed areas of skin and is the most common form of chronic cutaneous lupus erythematosus. Vitiligo is also an autoimmune disease known to be associated with other autoimmune conditions. However coexistence of DLE and vitiligo has been reported uncommonly. We report a case of a 60-year-old lady who developed DLE lesions over pre-existing vitiligo lesions.</p>
APA, Harvard, Vancouver, ISO, and other styles
7

Almurayshid, Abdurrahman, and Sulaiman Al Obaid. "Isolated Linear Discoid Lupus Erythematosus of Scalp Following Lines of Blaschko." Open Dermatology Journal 13, no. 1 (2019): 58–60. http://dx.doi.org/10.2174/1874372201913010058.

Full text
Abstract:
Discoid lupus erythematosus (DLE) is an inflammatory autoimmune disease leading to scarring and hair loss. Linear Discoid lupus erythematosus has been mentioned in the literature as a rare variant. This article describes isolated linear DLE of the scalp. We present a 26-year-old Saudi male who had unilateral linear DLE of the scalp with no involvement of other body sites and no systemic manifestations. This case is the first case of isolated linear DLE on the scalp. This presentation should be considered as a differential diagnosis of linear scarring alopecia as a distinct morphological patter
APA, Harvard, Vancouver, ISO, and other styles
8

Chikhalkar, Siddhi Bhalchandra, Surender Singh, Avani Jatin Kumar Shah, Bhushan Madke, and Yallappa Ramchandrappa Kabbannavar. "Halting the Progression of Cicatricial Alopecia with Injectable Platelet-Rich Fibrin." International Journal of Trichology 15, no. 4 (2023): 163–66. http://dx.doi.org/10.4103/ijt.ijt_116_21.

Full text
Abstract:
Discoid lupus erythematosus (DLE) is a chronic variant of cutaneous lupus erythematosus characterized by well-defined erythematous plaques with adherent scales and follicular plugging. The affected scalp shows erythema, edema, atrophy, alopecia, and telangiectasia. Trichoscopy of DLE shows branching capillaries, white patches, keratin plugs, reduced follicular ostia, and white dots and blue-gray dots arranged in speckles pattern. Prompt diagnosis and aggressive, early multimodal therapy helps in preventing disfiguring hair loss and psychosocial sequelae. Hereby, we present a case of reversal o
APA, Harvard, Vancouver, ISO, and other styles
9

Kishore Kumar, Pasupuleti, Pasumala Varun, Thokala Ruchitha, Chinta Rohit Kumar, and T. Rama Rao. "A case report on discoid lupus erythematosus." Indian Journal of Case Reports 11, no. 4 (2025): 169–71. https://doi.org/10.32677/ijcr.v11i4.5024.

Full text
Abstract:
Inflammatory plaques are a hallmark of discoid lupus erythematosus (DLE), a chronic cutaneous illness that can cause skin shrinkage and disfiguring scarring if left untreated. The best treatments, however, are not well supported by the available data. As of right now, no drugs have been authorized expressly to treat DLE. This uncommon ailment manifests as a crimson telangiectatic lesion in the oral cavity, surrounded by white patches in the mucous membrane. Occasionally, thick or thin white papillary radiating patterns are visible around the lesion as extremely thin lines. Here, we present a 2
APA, Harvard, Vancouver, ISO, and other styles
10

Rai, Harishchandra, Anitha Dayakar, Supriya H., and Elizabeth Sojan. "Discoid lupus erythematosus with epithelial dysplasia: a case report." International Journal of Research in Medical Sciences 5, no. 6 (2017): 2833. http://dx.doi.org/10.18203/2320-6012.ijrms20172501.

Full text
Abstract:
Lupus erythematosus is a classic example of an immunologically mediated condition and is one of the most common of the so called “collagen vascular” or connective tissue diseases. Lupus erythematosus was first described by Biett in 1828 and Kaposi in 1872. Development of squamous cell carcinoma (SCC) can occur in DLE, with about 20 cases reported in the world literature to-date, which led the World Health Organization (WHO) to classify DLE as one of the precancerous conditions. Thus malignant changes in such a condition must be given utmost importance. This article focuses on a rare case of DL
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Discoid lupus erythematosus (DLE)"

1

Meurer, Michael. "Childhood Discoid Lupus erythematosus and Antimalarials." Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2014. http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-135574.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Meurer, Michael. "Childhood Discoid Lupus erythematosus and Antimalarials." Karger, 2003. https://tud.qucosa.de/id/qucosa%3A27661.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wahie, Shyamal. "Response to hydroxychloroquine in discoid lupus erythematosus." Thesis, University of Newcastle Upon Tyne, 2011. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.580679.

Full text
Abstract:
Discoid Lupus Erythematosus (DLE) is the most common form of cutaneous lupus and causes irreversible facial scarring and disfigurement. Hydroxychloroquine is the oral therapy of choice. The factors influencing clinical response to hydroxychloroquine are unclear. Patients with Systemic Lupus Erythematosus (SLE) treated with hydroxychloroquine demonstrate a positive correlation between whole-blood hydroxychloroquine levels and clinical response. Variation in response to hydroxychloroquine might, in part, be due to genetic differences in the CYP450 genes responsible for hepatic metabolism of hydr
APA, Harvard, Vancouver, ISO, and other styles
4

Gomes, Roberta Cunha. "Características clínicas e laboratoriais de 847 pacientes com lúpus eritematoso sistêmico juvenil em três grupos etários ao diagnóstico da doença: um estudo multicêntrico brasileiro." Universidade de São Paulo, 2018. http://www.teses.usp.br/teses/disponiveis/5/5141/tde-07022019-161409/.

Full text
Abstract:
Introdução: A idade ao diagnóstico do lúpus eritematoso sistêmico juvenil (LESJ) pode influenciar a expressão da doença em termos de apresentação clínica inicial, padrão de envolvimento de órgãos e achados sorológicos. Objetivo: Avaliar dados demográficos, características clínicas e alterações laboratoriais no momento do diagnóstico da doença em três grupos etários diferentes de pacientes com LESJ: grupo A com início precoce (< 6 anos), grupo B com início em idade escolar ( >= 6 e < 12 anos) e grupo C com início em adolescentes ( >= 12 e < 18 anos). Métodos: Estudo multicêntrico brasileiro de
APA, Harvard, Vancouver, ISO, and other styles
5

Moure, Emanuella Rosyane Duarte. "Alopecias cicatriciais primárias: revisão de achados histopatológicos de 37 pacientes do Departamento de Dermatologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo no período de 2000 a 2005." Universidade de São Paulo, 2011. http://www.teses.usp.br/teses/disponiveis/5/5133/tde-18022011-143001/.

Full text
Abstract:
Introdução: As alopecias cicatriciais são subdivididas em primárias e secundárias. Nas alopecias cicatriciais primárias o folículo piloso é o alvo principal da destruição; diferentemente das secundárias onde a destruição folicular não é o evento patológico primário. Objetivo: Revisar os achados histológicos de pacientes com diagnóstico de alopecia cicatricial primária, em uma fase tardia e reclassificá-los em seus respectivos subtipos. Casuística e Métodos: Os espécimes de biópsia de pacientes com diagnóstico histológico prévio de alopecia cicatricial foram revisados e submetidos a colorações
APA, Harvard, Vancouver, ISO, and other styles
6

Saraiva, Miguel Filipe Porto Santos. "Manifestações Cutâneas do Lúpus Eritematoso. Relação com as suas Manifestações Sistémicas." Master's thesis, 2019. http://hdl.handle.net/10316/89622.

Full text
Abstract:
Trabalho Final do Mestrado Integrado em Medicina apresentado à Faculdade de Medicina<br>O Lupus eritematoso (LE) é uma doença autoimune que, atualmente, continua adespoletar muitas dúvidas e em relação ao qual ainda muito há por descobrir. Neste artigode revisão o objetivo fundamental foi perceber a importância das manifestações cutâneasnesta patologia. Manifestações cutâneas que podem aparecer isoladamente e sem qualquerenvolvimento sistémico ou que, por outro lado, podem surgir aquando de uma doençasistémica de base. Perceber a relação entre o aparecimento destas manifestações e apatologia d
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Discoid lupus erythematosus (DLE)"

1

1949-, Wallace Daniel J., Hahn Bevra та Dubois Edmund L, ред. Duboisʼ lupus erythematosus. 4-те вид. Lea & Febiger, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

L, Dubois Edmund, and Wallace Daniel J, eds. Dubois' Lupus erythematosus. 3rd ed. Lea & Febiger, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dubois, Edmund L., and Bevra Hahn. Lupus Erythematosus. 3rd ed. Lippincott Williams & Wilkins,US, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Wallace, Daniel J., and Bevra Hannahs Hahn. Dubois' Lupus Erythematosus. 7th ed. Lippincott Williams & Wilkins, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Swaniawski, Gay. Dermo Ointment: Effective Medication for the Treatment of Severe Forms of Skin Disorders Such As Psoriasis, Eczema and Discoid Lupus Erythematosus Caused by Low Immune System. Independently Published, 2019.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Berker, David de. Hair disorders. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0253.

Full text
Abstract:
This chapter discusses inflammatory scalp diseases and hair shedding (telogen effluvium and pattern hair loss). Inflammatory diseases of the scalp can affect all epidermal surfaces or focus upon the follicle, with relative sparing of the interfollicular skin. Eczema and psoriasis are examples of the former; other diseases, such as lichen planopilaris or discoid lupus erythematosus, are examples of the latter. Some follicular diseases, such as the family of diseases based on alopecia areata (alopecia areata (small areas of hair loss), alopecia totalis (whole scalp), and alopecia universalis (wh
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Discoid lupus erythematosus (DLE)"

1

Rudnicka, Lidia, Malgorzata Olszewska, and Adriana Rakowska. "Discoid Lupus Erythematosus." In Atlas of Trichoscopy. Springer London, 2012. http://dx.doi.org/10.1007/978-1-4471-4486-1_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Papadimitriou, Ilias, Efstratios Vakirlis, and Dimitrios Ioannides. "Discoid Lupus Erythematosus." In Hair Disorders. CRC Press, 2021. http://dx.doi.org/10.1201/9780429465154-12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Oboite, Michelle E., and Porcia B. Love. "Discoid Lupus Erythematosus." In Clinical Cases in Skin of Color. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-23615-5_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gammanpila, Ranthilaka R., and Eckart Haneke. "Discoid lupus erythematosus." In Dermatoses in Dark Vs Light Skin. CRC Press, 2025. https://doi.org/10.1201/9781003479512-50.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Molin, Lars. "Discoid Lupus Erythematosus Lesions Treated with Cryosurgery." In Rheumaderm. Springer US, 1999. http://dx.doi.org/10.1007/978-1-4615-4857-7_57.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bertoni, Laura, Camilla Reggiani, Paola Azzoni, Stefania Caramaschi, Luca Reggiani Bonetti, and Giovanni Pellacani. "Fluorescence Confocal Microscope for Identification of Discoid Lupus Erythematosus Histologic Features." In Cutaneous Atlas of Ex Vivo Confocal Microscopy. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-89316-3_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

"Lupus erythematosus, discoid." In Dermatology Therapy. Springer Berlin Heidelberg, 2004. http://dx.doi.org/10.1007/3-540-29668-9_1669.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

"Discoid lupus erythematosus." In Dermatology Therapy. Springer Berlin Heidelberg, 2004. http://dx.doi.org/10.1007/3-540-29668-9_829.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Jain, Sanjiv. "Discoid Lupus Erythematosus." In Fun with Dermatology. Jaypee Brothers Medical Publishers (P) Ltd., 1998. http://dx.doi.org/10.5005/jp/books/10312_43.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Malakar, Subrata, Samipa Mukherjee, and Surit Malakar. "Discoid Lupus Erythematosus." In Trichoscopy: A Text and Atlas. Jaypee Brothers Medical Publishers (P) Ltd., 2018. http://dx.doi.org/10.5005/jp/books/14121_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Discoid lupus erythematosus (DLE)"

1

Md Yusof, Md Yuzaiful, Miriam Wittmann, Catherine Fernandez, et al. "47 Targeted therapy using intradermal injection of etanercept for remission induction in discoid lupus erythematosus (TARGET-DLE): results from a proof-of-concept phase II trial." In 13th International Congress on Systemic Lupus Erythematosus (LUPUS 2019), San Francisco, California, USA, April 5–8, 2019, Abstract Presentations. Lupus Foundation of America, 2019. http://dx.doi.org/10.1136/lupus-2019-lsm.47.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Foch, Caroline, Sabrina de Souza, Ying Sun, et al. "P71 Treatment patterns, healthcare resource utilization and related costs of patients with discoid lupus erythematosus (DLE) or subacute cutaneous lupus erythematosus (SCLE) in the United States: a cohort study in the Merative™ MarketScan®database." In 14th European Lupus Meeting, Bruges, Belgium, March 19–22, 2024. Lupus Foundation of America, 2024. http://dx.doi.org/10.1136/lupus-2024-el.125.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Md Yusof, M. Y., M. Wittmann, C. Fernandez, et al. "FRI0328 Targeted therapy using intradermal injection of etanercept for remission induction in discoid lupus erythematosus (TARGET-DLE): first results from a proof-of-concept phase 2 trial." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.6623.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kesede, R. Julio, Luan L. Lee, and J. W. M. Bassani. "Automatic identification of Discoid Lupus Erythematosus." In 2011 ISSNIP Biosignals and Biorobotics Conference: Biosignals and Robotics for Better and Safer Living (BRC). IEEE, 2011. http://dx.doi.org/10.1109/brc.2011.5740668.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Solé-Marcé, C., T. Moline, B. Ferrer, G. Aparicio, and J. Cortés-Hernández. "POS0449 GENE THERAPY WITH INTERFERENCE miRNAs AS A NEW ALTERNATIVE FOR DISCOID CUTANEOUS LUPUS (DLE)." In EULAR 2024 European Congress of Rheumatology, 12-15 June. Vienna, Austria. BMJ Publishing Group Ltd and European League Against Rheumatism, 2024. http://dx.doi.org/10.1136/annrheumdis-2024-eular.4814.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mughni, Fadhli Aulia, Randy Satria Nugraha, Eyleny Meisyah Fitri, Tjhin Wiguna, and Windy Keumala Budianti. "Acute Cutaneous and Generalized Discoid Lupus Erythematosusin Systemic Lupus Erythematosus with Neuropsychiatric Complications: A Multidisciplinary Approach." In The 2nd International Conference on Tropical Medicine and Infectious Disease. SCITEPRESS - Science and Technology Publications, 2019. http://dx.doi.org/10.5220/0009987803200324.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Holtkamp, Hannah U., Federico Marini, Liam Quinn, et al. "Investigating changes in skin biochemistry due to Discoid Lupus Erythematosus using Raman Spectroscopy and Mass Spectrometry." In European Conference on Biomedical Optics. Optica Publishing Group, 2021. http://dx.doi.org/10.1364/ecbo.2021.em1a.25.

Full text
Abstract:
Discoid Lupus Erythematosus is a dermatological disease difficult to diagnose. By using Raman spectroscopy and MALDI mass spectrometry a shift in lipid biochemistry has been identified relative to healthy tissue, that can improve early detection.
APA, Harvard, Vancouver, ISO, and other styles
8

Cyert, Lynn. "Testing for Acquired Color Vision Deficiencies in Patients Receiving Hydroxychloroquine (Plaquenil) Therapy." In Advances in Color Vision. Optica Publishing Group, 1992. http://dx.doi.org/10.1364/acv.1992.fb17.

Full text
Abstract:
Hydroxychloroquine sulfate--trade name Plaquenil--is an antimalarial therapeutic agent derived from chloroquine. Hydroxychloroquine is also important for its use as an anti-inflammatory agent in the treatment of rheumatoid arthritis and discoid and systemic lupus erythematosus(1).
APA, Harvard, Vancouver, ISO, and other styles
9

Holtkamp, Hannah U., Claude Aguergaray, Michel K. Nieuwoudt, et al. "Developing multimodal imaging data analysis techniques: understanding the skin biochemistry of discoid lupus erythematosus." In Biomedical Spectroscopy, Microscopy, and Imaging II, edited by Jürgen Popp and Csilla Gergely. SPIE, 2022. http://dx.doi.org/10.1117/12.2621515.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Burhanuddin, Ika Saputri, Faridin Pango, Femi Syahriani, Endy Adnan, and Abdul Rahman Umar. "LP-157 Progressive discoid lupus related severe vasculitis – a rare case report." In The 15th International Congress on Systemic Lupus Erythematosus and The 43rd KCR Annual Scientific Meeting & 17th International Symposium (LUPUS & KCR 2023). Lupus Foundation of America, 2023. http://dx.doi.org/10.1136/lupus-2023-kcr.240.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!